Arvinas (ARVN) Just Made Protein Degrader History With FDA Nod
On August 4, Arvinas Inc. (NASDAQ:ARVN) reported second-quarter 2026 financial results and a corporate update that doubled as one of the more consequential updates in the company's history.





